| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:367.)
© 2005 American Heart Association, Inc.
Comments, Opinions, and Reviews |
From the Department of General Neurology (K.G., A.R., J.B.S., A.K.), University of Tübingen, Germany; the Department of Neurology (K.G., A.K.), University of Jena, Germany; and the Department of Neuroradiology (U.E.), University of Tübingen, Germany.
Correspondence to Dr Andreas Kastrup, Department of Neurology, Friedrich-Schiller-University of Jena, Erlanger Allee 101, 07747 Jena, Germany. E-mail andreas.kastrup{at}uni-jena.de
Background and Purpose Carotid angioplasty and stenting (CAS) has emerged as a potential alternative to endarterectomy (CEA) for the treatment of carotid artery disease. Aside from the periprocedural complication rates, the benefits of CAS will be affected by the incidence of recurrent carotid stenosis.
Methods We conducted a systematic analysis of all peer-reviewed studies reporting on the rate of restenosis (
50%) after CAS based on duplex ultrasound or angiography that were published between January 1990 and July 2004. We identified 34 studies that reported on a total of 4185 patients with a follow-up of 3814 arteries over a median of 13 months (range, 6 to 31 months). The ultrasound criteria and the lower thresholds for defining a recurrent stenosis were very heterogeneous.
Results The cumulative restenosis rates after 1 and 2 years were
6% and 7.5% in those studies, which used a lower restenosis threshold
50% to 70% and
4% in the first 2 years after CAS in those studies, which used a lower restenosis threshold >70% to 80%.
Conclusions In reviewing the current literature, the early restenosis rates after CAS compare well with those reported for CEA. However, this analysis of the peer-reviewed literature also indicates that the early restenosis rates after CAS might be higher than previously suggested in observational surveys. Therefore, an active follow-up of all stented arteries seems to be warranted. Moreover, the bulk of endovascular data are derived from small studies with short follow-up periods so that the long-term durability of CAS still needs to be established in large trials. Ideally, these studies should use a clear and uniform definition of restenosis and identical follow-up schedules.
Key Words: angioplasty carotid arteries outcome stenosis stents
This article has been cited by other articles:
![]() |
K. Groschel, S. Schnaudigel, S. M. Pilgram, K. Wasser, and A. Kastrup A Systematic Review on Outcome After Stenting for Intracranial Atherosclerosis Stroke, May 1, 2009; 40(5): e340 - e347. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Denes, Z. Bori, E. Csonka, L. Entz, and Z. Nagy Reverse Regulation of Endothelial Cells and Myointimal Hyperplasia on Cell Proliferation by a Heatshock Protein-Coinducer After Hypoxia Stroke, March 1, 2008; 39(3): 1022 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pelz, T. Andersson, M. Soderman, P. Lylyk, and M. Negoro Advances in Interventional Neuroradiology 2005 Stroke, February 1, 2006; 37(2): 309 - 311. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |